Agfa shows Web-enabled CIS, introduces comprehensive congenital reporting and analysis tool
At the World Congress of Cardiology held in Barcelona this week, Agfa HealthCare demonstrated its leading cardiology solution: Agfa Heartlab Cardiovascular. The event also marks the European debut of Heartlab Congenital, the world’s most comprehensive and flexible reporting and analysis tool for congenital echocardiography reporting.
Consolidating information from multiple cardiology subspecialties, Agfa Heartlab Cardiovascular improves departmental workflow, enables faster and more accurate diagnosis, and creates a comprehensive digital cardiac record. More than 20 facilities on the world market have recently placed orders for Agfa’s vendor neutral solution that connects all modality equipment.
Heart defects are among the most common birth defects and are the leading cause of birth-defect-related deaths, according to the American Heart Association. Advances in diagnosis and surgical treatment have led to dramatic increases in survival for children with serious heart defects, which has in turn led to a growing population of adults with congenital heart disease.
Consolidating information from multiple cardiology subspecialties, Agfa Heartlab Cardiovascular improves departmental workflow, enables faster and more accurate diagnosis, and creates a comprehensive digital cardiac record. More than 20 facilities on the world market have recently placed orders for Agfa’s vendor neutral solution that connects all modality equipment.
Heart defects are among the most common birth defects and are the leading cause of birth-defect-related deaths, according to the American Heart Association. Advances in diagnosis and surgical treatment have led to dramatic increases in survival for children with serious heart defects, which has in turn led to a growing population of adults with congenital heart disease.